| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 386,169 | 486,735 | 593,835 | 711,162 | | Cost of Revenue | 355,748 | 314,888 | 508,596 | 548,448 | | | Gross Profit | 30,421 | 171,847 | 85,239 | 162,714 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (23,147) | 62,520 | 14,961 | 44,076 | | Non Recurring | (14,531) | (238) | 17,588 | (352) | | Others | 36,352 | 40,205 | 88,469 | 41,589 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 31,747 | 69,360 | (35,779) | 77,401 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 420 | 741 | 53,653 | 3,127 | | Earnings Before Interest And Taxes | 32,167 | 70,101 | 17,874 | 80,528 | | Interest Expense | 10,166 | 9,853 | 6,804 | 6,410 | | Income Before Tax | 22,001 | 60,248 | 11,070 | 74,118 | | Income Tax Expense | 5,323 | 13,627 | 16,209 | 7,300 | | Minority Interest |
-
|
-
|
-
| (201) | | | | Net Income From Continuing Ops | 16,678 | 46,621 | (5,139) | 66,617 | | | Non-recurring Events | | Discontinued Operations | (1,319) | (5,657) | 946 | 3,246 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 15,359 | 40,964 | (4,193) | 69,863 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $15,359 | $40,964 | ($4,193) | $69,863 |
|
0.29% Nasdaq 0.00%
Income Statement
